Member Info for BOJO2020

I think you are correct FTSE buyer. As I recall Lindy, hoped' to update us by the end of January. However as you will see from the latest RNS dated 25th Jan 23. This has now changed to Q1 2023.

"The COVIDITY programme, focusing on the Company's novel COVID-19 vaccine candidates SCOV1 and SCOV2, recently completed dosing in South Africa and we expect to report safety and immunogenicity data in Q1 2023."

We can only go off the latest RNS (with special attention to Modi 1) which states dose escalation is gradually being ramped up. It did not mention full dose within or following the period. We can ‘assume’ full dose in due course, by now? It has not been confirmed or intimated by the latest RNS

And I have lived in Dunston, Durham and Spenny!

Great people up there.

I'll have to have a wee dram to keep me spirits up whilst I think of a fishy joke to join in. Hake just can't think of any :-( Maybe salmon else can think of one for me?

WF,

If you transfer the RNS into Microsoft Word you can have it on, 'read aloud,' with the read back function. Not many of us have the time to sit and read all 21 pages! I find it helps to both read and listen. Just an idea from one busy person to another.

Looking forward to your take on the update which I expect will be realistic, constructive and sensible!

Take Care

I don’t mind getting back from walking the dog at around 7.30. I see a red dot, notice 140 posts, and hope for good news! If it is then I will treat the little scamp to a bacon sandwich :-)

And the dog too!

Well done Avacta. No small achievement but it’s phase 1. Needs more data and an experienced partner. Very complex even at this stage. How effective is the drug? We know it is established and somewhat effective but it’s not just about targeting is it? Have to say that Avacta has a cult following including much of the twiterrati ; Myles McNulty, Paul Hill. Talk of partners and collabs. Talk of lots of things…No matter what, we must respect the scientific achievements. They are no competition to us. Good luck to them. We will be fine without Myles and Paul. Lindy and Co appear to have friends in the right places.

What do you think of Angle MJ? Did you buy in yet.

Avacta flying atm. Great update. Another one I am not invested in. Looks way over priced considering there has not been any tumor response. Or, did I miss that RNS?

Telegram MJ

Search Parsortix Angle for Angle group. Also a link on twitter

ODTT crew for all the old posters like Maf, John etc

Angle funds include:

So over 20% of Angle now owned by US investors, Fidelity, MS, Conifer and now Global Frontier. Apart from BG, all UK fund managers sitting it out.

From another poster

Lol Ruck,

You’re 10.20. Like the way you ‘articulated’ that.

More great news as they have a second responder! My question is, does Scancell? Clear differences between the two vaccines but it appears SCLP either have a super responder to Moditope or maybe more to its pan cancer vaccine. Soon find out in it's basket trial with update due...

Scancell has not finished its organic development yet. Taking it out in the near term may disrupt future Modi's. Let it grow! The company appears to be hitting its sweet spot right now.

I’d say we will see results regardless of talks. If they are good enough to prompt negotiations then the market must know about them. No harm caused to potential suitors if results are made public.

Nolu,

Looking at Hemo. It seems to have a higher volume than IQAI. Both seen impressive and sustained rises against the tide so to speak. Hope you are still in both?

The other group is till going strong. Maf, John, Wilbo, XV, and the others have have asked me to reiterate that your views would be valid and welcome over there. Door is always open! That applies to you Troajan too.

I do a bit of both which works out well for me.

ATB.

Chester,

Very keen for data on all fronts but most certainly Modi -1 and AvidiMab. Who knows exactly what and when but should have no shortage of discussion points. I am sure you will keep track of things for us.

All the best.

Angle is like the last biscuit on the plate. Everybody wants it but they are too shy to grab it. Once one makes a move all hell will break loose. A tremendous fight ensue that will eclipse the epic Cleaver and Mark Darcy fight for dear Bridgette Jones.

Newbies are not stupid. They are highly likely well researched and have been sitting on the side lines waiting for an opportunity like this! They won’t be discouraged by hints of a fund raise.

Yes when Jupiter sold went down to 40p before battering a bin lid shortly after!